New Inflammatory Biomarker Predicts Elevated Thrombosis Risk in Cancer Patients
Citrullinated histone 3 found to be associated with increased risk of thrombosis and inflammation
Citrullinated histone 3 found to be associated with increased risk of thrombosis and inflammation
Learn about the different approaches that scientists are taking towards precision medicine
We bring you insights, tips and knowledge from 11 experts as they tackle biomarker research using diverse methods
Discover the nano-LC technology enabling lipidomic research
SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies
The findings could help clinicians decide the best course and delivery of treatment for cancer patients
Breakthrough research of faecal metabolites could lead to personalized obesity treatments within a decade
The immunoassay is the market’s first validated high-performance multiplex screening panel
The test will expand the range of diagnostic options available to guide the treatment of Plasmodium vivax
Boosting T cell memory may result in long-lasting and effective responses for patients treated with checkpoint blockade immunotherapies
CYC065, an inhibitor of CDK2 and CDK9 kinases, has inhibited tumor growth in some patients with advanced cancers
During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research